EG 427
About:
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
Website: https://www.eg427.com
Top Investors: David Lamond, Stephane Boissel
Description:
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
Total Funding Amount:
17M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2019-01-01
Founders:
Alberto Epstein, François Giuliano, Philippe Chambon
Number of Employees:
11-50
Last Funding Date:
2023-07-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai